Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity.
作者信息
Rajabally Yusuf A
机构信息
School of Life and Health Sciences, Aston Brain Centre, Aston University, Birmingham, United Kingdom.
出版信息
EBioMedicine. 2016 Apr;6:12-13. doi: 10.1016/j.ebiom.2016.03.026. Epub 2016 Mar 19.
Abstract
摘要
相似文献
1
Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity.慢性炎症性脱髓鞘性多发性神经病的新型治疗途径：疾病多样性的难题
EBioMedicine. 2016 Apr;6:12-13. doi: 10.1016/j.ebiom.2016.03.026. Epub 2016 Mar 19.
2
Management strategies in chronic inflammatory demyelinating polyradiculoneuropathy.慢性炎症性脱髓鞘性多发性神经根神经病的治疗策略。
Neurol India. 2010 May-Jun;58(3):351-60. doi: 10.4103/0028-3886.65534.
3
Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.糖尿病患者的慢性炎症性脱髓鞘性多发性神经根神经病
Muscle Nerve. 2003 Apr;27(4):465-70. doi: 10.1002/mus.1250.
4
Observations on chronic inflammatory demyelinating polyneuropathy: A plea for a rigorous approach to diagnosis and treatment.
J Neurol Sci. 2013 Jul 15;330(1-2):2-3. doi: 10.1016/j.jns.2013.04.015. Epub 2013 May 8.
5
Unconventional treatments for chronic inflammatory demyelinating polyneuropathy.慢性炎症性脱髓鞘性多发性神经病的非常规治疗方法。
Neurodegener Dis Manag. 2017 Oct;7(5):331-342. doi: 10.2217/nmt-2017-0017. Epub 2017 Oct 18.
6
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.慢性炎症性脱髓鞘性多发性神经根神经病（CIDP）：临床特征、诊断及当前治疗策略
R I Med J (2013). 2016 Dec 1;99(12):32-35.
7
Assessing the benefit of treatment in chronic inflammatory demyelinating polyneuropathy: the challenges of clinical practice.
Neurodegener Dis Manag. 2018 Oct;8(5):285-288. doi: 10.2217/nmt-2018-0027. Epub 2018 Sep 18.
8
Chronic inflammatory demyelinating polyneuropathy (CIDP).
Electroencephalogr Clin Neurophysiol Suppl. 1999;50:493-8.
9
Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.慢性炎症性脱髓鞘性多发性神经病的新型免疫治疗策略
Immunotherapy. 2016 Feb;8(2):165-78. doi: 10.2217/imt.15.107. Epub 2016 Jan 25.
10
Atypical childhood chronic inflammatory demyelinating polyneuropathy.非典型儿童慢性炎症性脱髓鞘性多发神经病。
Muscle Nerve. 2010 Aug;42(2):293-5. doi: 10.1002/mus.21703.
引用本文的文献
1
IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety.静脉注射免疫球蛋白治疗明显的自身免疫性小纤维多发性神经病：疗效与安全性的首次分析
Ther Adv Neurol Disord. 2018 Jan 8;11:1756285617744484. doi: 10.1177/1756285617744484. eCollection 2018.
本文引用的文献
1
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.慢性炎症性脱髓鞘性多发性神经根神经病中的人类内源性逆转录病毒与神经炎症
EBioMedicine. 2016 Apr;6:190-198. doi: 10.1016/j.ebiom.2016.03.001. Epub 2016 Mar 10.
2
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.慢性炎症性脱髓鞘性多发性神经病中的神经束膜蛋白-155 IgG4
Neurology. 2016 Mar 1;86(9):800-7. doi: 10.1212/WNL.0000000000002418. Epub 2016 Feb 3.
3
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.利妥昔单抗治疗针对连接蛋白抗体阳性的难治性 CIDP。
Neurol Neuroimmunol Neuroinflamm. 2015 Sep 3;2(5):e149. doi: 10.1212/NXI.0000000000000149. eCollection 2015 Oct.
4
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.慢性炎症性脱髓鞘性多发性神经根神经病：从病理到表型
J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):973-85. doi: 10.1136/jnnp-2014-309697. Epub 2015 Feb 12.
5
Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.“典型”和“非典型”慢性炎症性脱髓鞘性多发性神经病的不同电生理特征和治疗反应。
J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1054-9. doi: 10.1136/jnnp-2014-308452. Epub 2014 Nov 25.
6
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.一项针对多发性硬化症患者的IIa期随机临床研究，该研究使用了GNbAC1，一种针对与多发性硬化症相关的内源性逆转录病毒包膜蛋白的人源化单克隆抗体。
Mult Scler. 2015 Jun;21(7):885-93. doi: 10.1177/1352458514554052. Epub 2014 Nov 12.
7
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.多发性硬化症相关逆转录病毒与多发性硬化症的进行性残疾。
Mult Scler. 2010 Oct;16(10):1248-51. doi: 10.1177/1352458510376956. Epub 2010 Aug 4.
8
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.欧洲神经病学会联合会/周围神经学会关于慢性炎症性脱髓鞘性多发性神经病管理指南：欧洲神经病学会联合会和周围神经学会联合工作组的报告-第一版修订。
Eur J Neurol. 2010 Mar;17(3):356-63. doi: 10.1111/j.1468-1331.2009.02930.x.
9
Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population.不同诊断标准下慢性炎症性脱髓鞘性多发性神经病的流行病学变异性：一项英国人群研究
Muscle Nerve. 2009 Apr;39(4):432-8. doi: 10.1002/mus.21206.
10
Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.多发性硬化症（MS）患者的大脑和外周血单核细胞过度表达与MS相关的逆转录病毒/HERV-W内源性逆转录病毒，但不表达人疱疹病毒6。
J Gen Virol. 2007 Jan;88(Pt 1):264-274. doi: 10.1099/vir.0.81890-0.
Zotero 插件